<div id="readability-page-1"><p>NewEdge Advisors LLC trimmed its position in  Medtronic PLC (NYSE:MDT - Free Report) by 37.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 136,203 shares of the medical technology company's stock after selling 81,417 shares during the quarter. NewEdge Advisors LLC's holdings in Medtronic were worth $11,873,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li></ul><p>Other institutional investors have also added to or reduced their stakes in the company. Gilbert &amp; Cook Inc. raised its stake in shares of  Medtronic by 1.9% during the second quarter. Gilbert &amp; Cook Inc. now owns 6,103 shares of the medical technology company's stock valued at $532,000 after acquiring an additional 114 shares during the last quarter.  Red Spruce Capital LLC increased its holdings in  Medtronic by 0.5% during the 2nd quarter. Red Spruce Capital LLC now owns 23,707 shares of the medical technology company's stock valued at $2,067,000 after purchasing an additional 118 shares during the period.  Certior Financial Group LLC raised its position in  Medtronic by 3.7% during the 1st quarter. Certior Financial Group LLC now owns 3,450 shares of the medical technology company's stock valued at $310,000 after purchasing an additional 122 shares during the last quarter.  Cary Street Partners Investment Advisory LLC lifted its holdings in  Medtronic by 6.0% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 2,191 shares of the medical technology company's stock worth $191,000 after buying an additional 124 shares during the period.  Finally, PrairieView Partners LLC grew its position in shares of  Medtronic by 3.6% in the 2nd quarter. PrairieView Partners LLC now owns 3,726 shares of the medical technology company's stock worth $324,000 after buying an additional 128 shares during the last quarter. Hedge funds and other institutional investors own  82.06% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>MDT has been the subject of a number of recent analyst reports. The Goldman Sachs Group  set a $111.00 target price on Medtronic and gave the company a &#34;neutral&#34; rating in a report on Wednesday, November 19th. Barclays upped their price objective on shares of Medtronic from $109.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a report on Thursday, November 20th. Argus lifted their target price on shares of Medtronic from $105.00 to $115.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, August 26th. Sanford C. Bernstein  set a $111.00 price target on shares of Medtronic in a research report on Wednesday, November 19th. Finally, Stifel Nicolaus raised their price objective on shares of Medtronic from $90.00 to $105.00 and gave the stock a &#34;hold&#34; rating in a report on Thursday, October 9th. One research analyst  has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. According to MarketBeat, Medtronic presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $110.44.</p><ul><li>MarketBeat Week in Review – 08/18 - 08/22</li></ul><p><b>Get Our Latest Stock Report on MDT</b></p><h2>Medtronic Stock Down 1.0%</h2><p>Shares of Medtronic stock opened at $99.77 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. The company has a 50-day moving average of $97.23 and a 200 day moving average of $92.66. The firm has a market cap of $127.91 billion, a price-to-earnings ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a 1 year low of $79.29 and a 1 year high of $106.33. </p><ul><li>Medtronic: The Opportunity Gets Healthier for Income Investors</li></ul><p>Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business had revenue of $8.96 billion for the quarter, compared to analyst estimates of $8.86 billion. During the same quarter in the previous year, the firm posted $1.26 earnings per share. Medtronic's quarterly revenue was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS.  As a group, sell-side analysts anticipate that  Medtronic PLC will post 5.46 earnings per share for the current fiscal year. </p><h2>Medtronic Dividend Announcement</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio (DPR) is 76.55%. </p><h2>About Medtronic</h2> (Free Report)<p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p><h2>See Also</h2><ul><li>Five stocks we like better than Medtronic</li><li>How to Calculate Retirement Income: MarketBeat’s Calculator</li><li>3 Recently Downgraded Stocks to Avoid in 2026</li><li>How to Effectively Use the MarketBeat Ratings Screener</li><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li><li>Stock Splits, Do They Really Impact Investors?</li><li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li></ul><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Medtronic Right Now?</h2><p>Before you consider Medtronic, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>NewEdge Advisors LLC reduced its stake in Medtronic PLC by 37.4% in Q2, selling 81,417 shares. The firm now holds 136,203 shares valued at $11.87 million. Other institutional investors also adjusted their positions in Medtronic. Analysts have set new price targets, with a consensus rating of 'Moderate Buy' and a price target of $110.44. Medtronic's stock opened at $99.77, with a market cap of $127.91 billion. The company reported Q2 earnings of $1.36 per share, beating estimates, and revenue of $8.96 billion, up 6.6% year-over-year.</p>

NewEdge Advisors LLC Sells 81,417 Shares of Medtronic PLC $MDT